Pedro Lichtinger

Pedro Lichtinger is Chair and CEO of Starton Therapeutics and is an industry executive with a career that spans more than 40 years in biotechnology. He has a proven track record of managing and developing business, executing strategic alliances, and building commercial and R&D capabilities.

He is the former President of Global Primary Care and former President of Europe at Pfizer Inc with 16 years of experience. He’s the former President and CEO of Asterias Biotherapeutics, and the former President and CEO of Optimer Pharmaceuticals.

Mr. Lichtinger holds an MBA degree from Wharton School of Business and an engineering degree from the National University of Mexico.